Source:http://linkedlifedata.com/resource/pubmed/id/20800895
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2010-11-29
|
pubmed:abstractText |
Innate immune responses including TLR4 and complement activation are required for mesenteric ischemia/reperfusion (IR)-induced tissue damage. We examined the regulation of TLR4 and complement activation in a mouse model of intestinal IR. Intestinal IR-induced C3 deposition in a TLR4 dependent manner. In addition, in wild-type but not TLR4 deficient mice, IR significantly increased C3 and Factor B (FB) mRNA expression within the intestine. To further examine the role of TLR4 and complement, we administered the complement inhibitor, CR2-Crry, to target local complement activation in wild-type C57Bl/10, and TLR4 deficient B10/ScN mice. TLR4 deficient mice sustained less damage and inflammation after IR than wild-type mice, but administration of CR2-Crry did not further reduce tissue damage. In contrast, CR2-Crry treatment of wild-type mice was accompanied by a reduction in complement activation and in C3 and FB transcription in response to IR. CR2-Crry also significantly decreased intestinal IL-6 and IL-12p40 production in both the wild-type and TLR4 deficient mice. These data indicate that TLR4 regulates extrahepatic complement production while complement regulates TLR4-mediated cytokine production during intestinal IR.
|
pubmed:grant |
http://linkedlifedata.com/resource/pubmed/grant/AI061691,
http://linkedlifedata.com/resource/pubmed/grant/P20 RR017686,
http://linkedlifedata.com/resource/pubmed/grant/P20 RR017686-085967,
http://linkedlifedata.com/resource/pubmed/grant/R01 AI061691-04,
http://linkedlifedata.com/resource/pubmed/grant/R01 AI061691-05,
http://linkedlifedata.com/resource/pubmed/grant/RR016475
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
1872-9142
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Ltd. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
48
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
356-64
|
pubmed:dateRevised |
2011-11-1
|
pubmed:meshHeading |
pubmed-meshheading:20800895-Animals,
pubmed-meshheading:20800895-Complement Activation,
pubmed-meshheading:20800895-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20800895-Inflammation,
pubmed-meshheading:20800895-Intestines,
pubmed-meshheading:20800895-Mice,
pubmed-meshheading:20800895-Mice, Inbred C57BL,
pubmed-meshheading:20800895-Mice, Mutant Strains,
pubmed-meshheading:20800895-Reperfusion Injury,
pubmed-meshheading:20800895-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:20800895-Toll-Like Receptor 4
|
pubmed:articleTitle |
Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion.
|
pubmed:affiliation |
Division of Biology, Kansas State University, Manhattan, KS 66506, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|